926 related articles for article (PubMed ID: 17591692)
21. The aryl hydrocarbon receptor activates the retinoic acid receptoralpha through SMRT antagonism.
Widerak M; Ghoneim C; Dumontier MF; Quesne M; Corvol MT; Savouret JF
Biochimie; 2006; 88(3-4):387-97. PubMed ID: 16480812
[TBL] [Abstract][Full Text] [Related]
22. Neuroanatomical distribution and colocalisation of nuclear receptor corepressor (N-CoR) and silencing mediator of retinoid and thyroid receptors (SMRT) in rat brain.
van der Laan S; Lachize SB; Schouten TG; Vreugdenhil E; de Kloet ER; Meijer OC
Brain Res; 2005 Oct; 1059(2):113-21. PubMed ID: 16212947
[TBL] [Abstract][Full Text] [Related]
23. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.
Sarvilinna N; Eronen H; Miettinen S; Vienonen A; Ylikomi T
Int J Cancer; 2006 Feb; 118(4):832-40. PubMed ID: 16152593
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.
Söderström M; Vo A; Heinzel T; Lavinsky RM; Yang WM; Seto E; Peterson DA; Rosenfeld MG; Glass CK
Mol Endocrinol; 1997 Jun; 11(6):682-92. PubMed ID: 9171232
[TBL] [Abstract][Full Text] [Related]
25. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
Huang HJ; Norris JD; McDonnell DP
Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334
[TBL] [Abstract][Full Text] [Related]
26. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
27. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
28. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
29. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
Loinder K; Söderström M
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
[TBL] [Abstract][Full Text] [Related]
30. Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor.
Kim JY; Son YL; Lee YC
Mol Endocrinol; 2009 Feb; 23(2):251-64. PubMed ID: 19098224
[TBL] [Abstract][Full Text] [Related]
31. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha.
Yan J; Gao Z; Yu G; He Q; Weng J; Ye J
Mol Endocrinol; 2007 Jul; 21(7):1630-41. PubMed ID: 17456789
[TBL] [Abstract][Full Text] [Related]
32. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
33. Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.
Smith CL; Migliaccio I; Chaubal V; Wu MF; Pace MC; Hartmaier R; Jiang S; Edwards DP; Gutiérrez MC; Hilsenbeck SG; Oesterreich S
Breast Cancer Res Treat; 2012 Nov; 136(1):253-65. PubMed ID: 23015261
[TBL] [Abstract][Full Text] [Related]
34. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.
Tomita A; Buchholz DR; Shi YB
Mol Cell Biol; 2004 Apr; 24(8):3337-46. PubMed ID: 15060155
[TBL] [Abstract][Full Text] [Related]
35. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element.
Berghagen H; Ragnhildstveit E; Krogsrud K; Thuestad G; Apriletti J; Saatcioglu F
J Biol Chem; 2002 Dec; 277(51):49517-22. PubMed ID: 12388540
[TBL] [Abstract][Full Text] [Related]
36. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
37. p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.
Carroll JS; Lynch DK; Swarbrick A; Renoir JM; Sarcevic B; Daly RJ; Musgrove EA; Sutherland RL
Cancer Res; 2003 Aug; 63(15):4322-6. PubMed ID: 12907598
[TBL] [Abstract][Full Text] [Related]
38. Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor.
Rokutanda N; Iwasaki T; Odawara H; Nagaoka R; Miyazaki W; Takeshita A; Koibuchi Y; Horiguchi J; Shimokawa N; Iino Y; Morishita Y; Koibuchi N
Endocrine; 2008 Jun; 33(3):305-16. PubMed ID: 19011999
[TBL] [Abstract][Full Text] [Related]
39. The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression.
Rushing SR; Denison MS
Arch Biochem Biophys; 2002 Jul; 403(2):189-201. PubMed ID: 12139968
[TBL] [Abstract][Full Text] [Related]
40. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene.
van der Laan S; Lachize SB; Vreugdenhil E; de Kloet ER; Meijer OC
Endocrinology; 2008 Feb; 149(2):725-32. PubMed ID: 18006628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
